loading

Gilead Sciences Inc 주식(GILD)의 최신 뉴스

pulisher
Mar 21, 2025

Insider Sell: Andrew Dickinson Sells Shares of Gilead Sciences Inc (GILD) - GuruFocus.com

Mar 21, 2025
pulisher
Mar 21, 2025

Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics - Yahoo Finance

Mar 21, 2025
pulisher
Mar 20, 2025

Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance

Mar 20, 2025
pulisher
Mar 20, 2025

GILD Stock Down on Report of Cut in HIV Prevention Spending - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Oppenheimer doesn’t see threat to Gilead estimates after HHS plans for HIV cuts - Yahoo Finance

Mar 20, 2025
pulisher
Mar 20, 2025

Gilead Stock Wobbles On Federal HIV Funding Cut Buzz, But Retail And Analysts Stay Unfazed - MSN

Mar 20, 2025
pulisher
Mar 19, 2025

Trump Administration Weighs Deep Cuts To Domestic HIV Prevention Programs, Gilead Stock Slides - Yahoo Finance

Mar 19, 2025
pulisher
Mar 19, 2025

Gilead Stock Falls on Report U.S. Could Slash HIV-Prevention Budget - The Wall Street Journal

Mar 19, 2025
pulisher
Mar 19, 2025

Gilead stock falls on report of HIV prevention cuts - Yahoo Finance

Mar 19, 2025
pulisher
Mar 19, 2025

Gilead Stock Dives On A Devastating Potential Call From HHS - Investor's Business Daily

Mar 19, 2025
pulisher
Mar 19, 2025

Stock of the Day: Gilead Sciences falls on report the Trump administration could slash funds for HIV prevention - Yahoo Finance

Mar 19, 2025
pulisher
Mar 19, 2025

Wall Street weighs in on Gilead as shares fall on possible U.S. HIV cuts - Investing.com Canada

Mar 19, 2025
pulisher
Mar 19, 2025

BMO reiterates Gilead stock with $115 target amid HIV funding concerns - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Citi maintains Gilead stock Buy rating, $125 target amid HIV funding fears - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Gilead Sciences Should Not See Any Impact From HIV-Related Cost Reductions at US Healthcare Department, Truist Says - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Gilead Sciences Ranked in Top Five Most JUST List for Biopharma Companies - CSRwire.com

Mar 19, 2025
pulisher
Mar 19, 2025

Gilead Sciences’ SWOT analysis: HIV giant’s stock faces pivotal transition - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Gilead Sciences Stock Slips on Possible HIV Funding Cut - Schaeffers Research

Mar 19, 2025
pulisher
Mar 19, 2025

Why Gilead Sciences (GILD) Is Among the Most Undervalued Biotech Stocks to Invest In - Insider Monkey

Mar 19, 2025
pulisher
Mar 19, 2025

Citi Defending Gilead Sciences (GILD): 'we are buyers of GILD stock on any weakness ahead of the upcoming Len PrEP launch in mid-2025' - StreetInsider.com

Mar 19, 2025
pulisher
Mar 19, 2025

Gilead Stock Falls on Report Trump Administration Wants to Cut HIV-Prevention Funding - Barron's

Mar 19, 2025
pulisher
Mar 19, 2025

Gilead Stock (NYSE:GILD) Slumps on HIV Funding Cuts Report - TipRanks

Mar 19, 2025
pulisher
Mar 19, 2025

Gilead slides as Trump administration puts HIV prevention funds under review - TradingView

Mar 19, 2025
pulisher
Mar 19, 2025

Gilead Sciences (GILD): Potential Impact of Federal HIV Funding Cuts - Value the Markets

Mar 19, 2025
pulisher
Mar 18, 2025

Gilead, GSK could be impacted by potential HHS HIV prevention cuts - Seeking Alpha

Mar 18, 2025
pulisher
Mar 18, 2025

Gilead Sciences CFO Andrew Dickinson sells $276,325 in stock - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

After-hours movers: Gilead Sciences, HealthEquity, CARGO Therapeutics and more - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Gilead Sciences stock falls on potential HIV funding cuts By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

Gilead Sciences stock falls on potential HIV funding cuts - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Unpacking the Latest Options Trading Trends in Gilead Sciences - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

Gilead Sciences (GILD): Among the Best Biotech Stocks to Buy According to Billionaires - Yahoo Finance

Mar 18, 2025
pulisher
Mar 17, 2025

Coronavirus: La Commission européenne signe un accord avec Gilead sur le remdesivir - Reuters

Mar 17, 2025
pulisher
Mar 17, 2025

Is Gilead Sciences, Inc. (GILD) a Best Biotech Stock According to Billionaires? - Yahoo Finance UK

Mar 17, 2025
pulisher
Mar 17, 2025

7 Most Undervalued Biotech Stocks To Invest In - Insider Monkey

Mar 17, 2025
pulisher
Mar 17, 2025

GILD Stock Trading Close to Its 52-Week High: Should You Buy or Sell? - Yahoo Finance

Mar 17, 2025
pulisher
Mar 17, 2025

Gilead SciencesWomen's History Month Celebrated With Its Team - CSRwire.com

Mar 17, 2025
pulisher
Mar 17, 2025

Is Gilead Sciences, Inc. (GILD) The Most Undervalued NASDAQ Stock To Buy According To Hedge Funds? - Insider Monkey

Mar 17, 2025
pulisher
Mar 16, 2025

Gilead: Growth Constraints Lead To Rating Downgrade Following 50% Rally - Seeking Alpha

Mar 16, 2025
pulisher
Mar 14, 2025

Gilead's accounting chief hits the exit—Chutes & Ladders - Fierce Biotech

Mar 14, 2025
pulisher
Mar 13, 2025

Gilead Sciences: A rare Nasdaq gem with consistent returns across time horizons - The Financial Express

Mar 13, 2025
pulisher
Mar 13, 2025

Merck’s HIV Combo Shows Non-Inferiority To Gilead’s Biktarvy - Citeline News & Insights

Mar 13, 2025
pulisher
Mar 13, 2025

Is Gilead Sciences Gaining or Losing Market Support? - Benzinga

Mar 13, 2025
drug_manufacturers_general SNY
$56.90
price down icon 1.54%
drug_manufacturers_general PFE
$26.28
price up icon 0.34%
$316.04
price up icon 0.32%
drug_manufacturers_general NVS
$112.13
price down icon 0.95%
drug_manufacturers_general MRK
$93.11
price down icon 1.71%
자본화:     |  볼륨(24시간):